ASO Author Reflections: Stage II/III Colorectal Cancer Patients with Mismatch Repair Deficiency Need More Personalized Adjuvant Chemotherapy

Ann Surg Oncol. 2024 Nov;31(12):7854-7855. doi: 10.1245/s10434-024-15926-1. Epub 2024 Jul 29.

Mian Chen^{1

2}, Shenghe Deng¹, Yinghao Cao^{3

4}, Liang Huang⁵, Kailin Cai⁶

¹ Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital Sun Yat-sen University, Guangzhou, Guangdong, China.
³ Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
⁴ Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
⁵ Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital Sun Yat-sen University, Guangzhou, Guangdong, China. [email protected].
⁶ Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [email protected].

No abstract available

MeSH terms